Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...

You know the drill by now. You're sitting in the purgatory of the service center waiting room. Precisely 63 minutes into your wait, the service adviser walks out with a clipboard and calls your name — ...

The best defense against prompt injection and other AI attacks is to do some basic engineering, test more, and not rely on AI to protect you. If you want to know what is actually happening in ...

Prompt injection vulnerabilities may never be fully mitigated as a category and network defenders should instead focus on ways to reduce their impact, government security experts have warned. Then ...

The UK’s National Cyber Security Centre (NCSC) has highlighted a potentially dangerous misunderstanding surrounding emergent prompt injection attacks against generative artificial intelligence (GenAI) ...

SAP has released its November security updates that address multiple security vulnerabilities, including a maximum severity flaw in the non-GUI variant of the SQL Anywhere Monitor and a critical code ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

This report presents the findings from a comprehensive web application security assessment conducted for Inlanefreight. The assessment focused on identifying SQL injection vulnerabilities within a ...

Fox News host Brian Kilmeade called for executing homeless individuals with mental health issues during a September 10 episode of Fox & Friends, suggesting "involuntary lethal injection" as a solution ...

Ozempic (semaglutide) is injected once weekly under the skin of your abdomen, upper arm, or thigh. Your doctor will show you how to do this before your first dose. To prevent skin issues, rotate your ...

Leqembi (lecanemab-irmb) is a prescription medicine approved to treat early stages of Alzheimer's disease, such as mild cognitive impairment or mild dementia. The recent FDA approval of Leqembi IQLIK ...